Prestige Consumer Healthcare (PBH)
(Delayed Data from NYSE)
$59.58 USD
+0.78 (1.33%)
Updated Jul 1, 2022 04:00 PM ET
4-Sell of 5 4
B Value C Growth F Momentum C VGM
Fundamental Charts
About PE Ratio (TTM)
Prestige Consumer Healthcare Inc. has a trailing-twelve-months P/E of 14.48X compared to the Consumer Products - Discretionary industry's P/E of 14.48X.
Price to Earnings Ratio or P/E is price / earnings. It is the most commonly used metric for determining a company's value relative to its earnings. In this example, we are using the actual earnings (EPS) for the trailing twelve months (or TTM). A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. In general, a lower number or multiple is usually considered better than a higher one.
PBH 59.58 +0.78(1.33%)
Will PBH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PBH based on the 1-3 month trading system that nearly triples the S&P 500.
Zacks News for PBH
Prestige Consumer (PBH) Brand-Building Efforts Solid, Costs High
Prestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat
PBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
Central Garden (CENT) Q2 Earnings and Revenues Beat Estimates
What's in Store for Prestige Consumer (PBH) in Q4 Earnings?
Other News for PBH
PBH Makes Bullish Cross Above Critical Moving Average
Australia stocks lower at close of trade; S&P/ASX 200 down 1.25%
Australia stocks higher at close of trade; S&P/ASX 200 up 0.32%
Australia stocks higher at close of trade; S&P/ASX 200 up 1.08%
Australia stocks lower at close of trade; S&P/ASX 200 down 0.69%